- Home
- ALLR vs MEGL Comparison
ALLR vs MEGL Comparison
Compare ALLR & MEGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- MEGL
- Stock Information
- Founded
- ALLR 2004
- MEGL 2016
- Country
- ALLR United States
- MEGL Hong Kong
- Employees
- ALLR N/A
- MEGL N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- MEGL Finance: Consumer Services
- Sector
- ALLR Health Care
- MEGL Finance
- Exchange
- ALLR Nasdaq
- MEGL Nasdaq
- Market Cap
- ALLR 4.0M
- MEGL 5.7M
- IPO Year
- ALLR N/A
- MEGL 2022
- Fundamental
- Price
- ALLR $0.87
- MEGL $1.26
- Analyst Decision
- ALLR
- MEGL
- Analyst Count
- ALLR 0
- MEGL 0
- Target Price
- ALLR N/A
- MEGL N/A
- AVG Volume (30 Days)
- ALLR 660.5K
- MEGL 2.8M
- Earning Date
- ALLR 05-09-2025
- MEGL 06-10-2025
- Dividend Yield
- ALLR N/A
- MEGL N/A
- EPS Growth
- ALLR N/A
- MEGL N/A
- EPS
- ALLR N/A
- MEGL N/A
- Revenue
- ALLR N/A
- MEGL $1,645,862.00
- Revenue This Year
- ALLR N/A
- MEGL N/A
- Revenue Next Year
- ALLR N/A
- MEGL N/A
- P/E Ratio
- ALLR N/A
- MEGL N/A
- Revenue Growth
- ALLR N/A
- MEGL N/A
- 52 Week Low
- ALLR $0.61
- MEGL $1.02
- 52 Week High
- ALLR $20.44
- MEGL $5.52
- Technical
- Relative Strength Index (RSI)
- ALLR 36.97
- MEGL 42.66
- Support Level
- ALLR $1.02
- MEGL $1.30
- Resistance Level
- ALLR $1.06
- MEGL $1.40
- Average True Range (ATR)
- ALLR 0.08
- MEGL 0.13
- MACD
- ALLR -0.03
- MEGL -0.03
- Stochastic Oscillator
- ALLR 12.56
- MEGL 6.02
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
About MEGL Magic Empire Global Limited
Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.